PS Ratio
14.10
+0.12+0.86%
Wed, 12 Feb 2025 09:16:17 GMT
Summary
- As of February 12, 2025, LGND price to sales ratio is 14.10, with a rise of +0.12 (+0.86%) during the most recent trading day.
- Over the past year, LGND PS ratio has increased by +3.81 (+37.03%).
- LGND PS ratio is now -98.20% below its all-time high of 785.10.
Performance
LGND PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
LGND PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +0.9% | +0.9% | +0.9% | +14.2% |
| 1 m1 month | +5.6% | +5.6% | +5.6% | - |
| 3 m3 months | -5.8% | -5.8% | -5.8% | +14.2% |
| 6 m6 months | +3.5% | +14.2% | +18.1% | - |
| ytdytd | +6.3% | +6.3% | +6.3% | - |
| 1 y1 year | +37.0% | +47.8% | +59.0% | -0.8% |
| 5 y5 years | +6.0% | +19.6% | +34.4% | -16.6% |
LGND PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.8% | 12.99 | +8.6% | |
| 3 m | 3-month | 15.56 | -9.4% | 12.40 | +13.7% |
| 6 m | 6-month | 16.36 | -13.8% | 11.89 | +18.6% |
| 1 y | 1-year | 16.36 | -13.8% | 9.07 | +55.5% |
| 3 y | 3-year | 16.36 | -13.8% | 4.88 | +188.9% |
| 5 y | 5-year | 21.22 | -33.5% | 4.88 | +188.9% |
| alltime | all time | 785.10 | -98.2% | -20.22 | +169.7% |
Ligand Pharmaceuticals Incorporated PS Ratio History
| Date | Value |
|---|---|
| 2025 | 14.10(+6.3%) |
| 2024 | 13.27(+38.8%) |
| 2023 | 9.56(+65.7%) |
| 2022 | 5.77(-46.2%) |
| 2021 | 10.72(+9.6%) |
| 2020 | 9.78(-33.0%) |
| 2019 | 14.59(+30.2%) |
| 2018 | 11.21(-45.4%) |
| 2017 | 20.52(+5.2%) |
| 2016 | 19.50(-35.2%) |
| 2015 | 30.08(+86.4%) |
| 2014 | 16.14(-26.6%) |
| 2013 | 21.98(+56.3%) |
| 2012 | 14.06(+81.9%) |
| 2011 | 7.73(+4.6%) |
| Date | Value |
|---|---|
| 2010 | 7.39(+13.7%) |
| 2009 | 6.50(-31.7%) |
| 2008 | 9.52(-73.0%) |
| 2007 | 35.32(+63.4%) |
| 2005 | 21.61(+249.1%) |
| 2004 | 6.19(-53.3%) |
| 2003 | 13.25(+147.7%) |
| 2002 | 5.35(-62.0%) |
| 2001 | 14.09(-13.1%) |
| 2000 | 16.21(-2.9%) |
| 1999 | 16.69(-44.4%) |
| 1998 | 30.01(+212.9%) |
| 1997 | 9.59(-25.0%) |
| 1996 | 12.78(+62.2%) |
| 1995 | 7.88 |
FAQ
- What is Ligand Pharmaceuticals Incorporated price to sales ratio?
- What is the all time high PS ratio for Ligand Pharmaceuticals Incorporated?
- What is LGND price to sales ratio year-to-date change?
- What is Ligand Pharmaceuticals Incorporated PS ratio year-on-year change?
What is Ligand Pharmaceuticals Incorporated price to sales ratio?
The current PS ratio of LGND is 14.10
What is the all time high PS ratio for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high price to sales ratio is 785.10
What is LGND price to sales ratio year-to-date change?
Ligand Pharmaceuticals Incorporated price to sales ratio has changed by +0.83 (+6.25%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated PS ratio year-on-year change?
Over the past year, LGND price to sales ratio has changed by +3.81 (+37.03%)